These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15233725)

  • 1. Targeting plasmid-encoded proteins to the antigen presentation pathways.
    Leifert JA; Rodriguez-Carreno MP; Rodriguez F; Whitton JL
    Immunol Rev; 2004 Jun; 199():40-53. PubMed ID: 15233725
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Mechanism of priming cytotoxic T cell response and strategy for enhancing DNA vaccine potency in DNA immunization].
    Deng X; Cai M
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Mar; 20(1):175-9. PubMed ID: 12744193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting antigen to MHC Class I and Class II antigen presentation pathways for malaria DNA vaccines.
    Dobaño C; Rogers WO; Gowda K; Doolan DL
    Immunol Lett; 2007 Aug; 111(2):92-102. PubMed ID: 17604849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving DNA vaccine potency via modification of professional antigen presenting cells.
    Hung CF; Wu TC
    Curr Opin Mol Ther; 2003 Feb; 5(1):20-4. PubMed ID: 12669466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming of CTL responses by DNA vaccines: direct transfection of antigen presenting cells versus cross-priming.
    Ulmer JB; Otten GR
    Dev Biol (Basel); 2000; 104():9-14. PubMed ID: 11713829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cross-priming pathway: a portrait of an intricate immune system.
    Basta S; Alatery A
    Scand J Immunol; 2007 Apr; 65(4):311-9. PubMed ID: 17386021
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with liposome--DNA complexes elicits enhanced antitumor immunity.
    U'Ren L; Kedl R; Dow S
    Cancer Gene Ther; 2006 Nov; 13(11):1033-44. PubMed ID: 16841080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cow, the boy and the lymph node--immunological principles for vaccines].
    Munthe LA
    Tidsskr Nor Laegeforen; 2006 Oct; 126(19):2532-7. PubMed ID: 17028635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viral immunity: cross-priming with the help of TLR3.
    Salio M; Cerundolo V
    Curr Biol; 2005 May; 15(9):R336-9. PubMed ID: 15886091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modifying professional antigen-presenting cells to enhance DNA vaccine potency.
    Hung CF; Yang M; Wu TC
    Methods Mol Med; 2006; 127():199-220. PubMed ID: 16988456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-immunisation with DNA encoding RANK/RANKL or 4-1BBL costimulatory molecules does not enhance effector or memory CTL responses afforded by immunisation with a tumour antigen-encoding DNA vaccine.
    Herd KA; Wiethe C; Tindle RW
    Vaccine; 2007 Jul; 25(28):5209-19. PubMed ID: 17544551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rational design of gene-based vaccines.
    Barouch DH
    J Pathol; 2006 Jan; 208(2):283-9. PubMed ID: 16362986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA vaccines increase immunogenicity of idiotypic tumor antigen by targeting novel fusion proteins to antigen-presenting cells.
    Fredriksen AB; Sandlie I; Bogen B
    Mol Ther; 2006 Apr; 13(4):776-85. PubMed ID: 16414309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
    Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
    Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen epitope-expressing cytokines for DNA immunization.
    He X; Tsang TC; Zhang T; Luo P; Harris DT
    Vaccine; 2005 Mar; 23(16):1966-72. PubMed ID: 15734069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of multiepitopic and long-lasting immune responses against tumour antigens by immunization with peptides, DNA and recombinant adenoviruses expressing minigenes.
    Durántez M; López-Vázquez AB; de Cerio AL; Huarte E; Casares N; Prieto J; Borrás-Cuesta F; Lasarte JJ; Sarobe P
    Scand J Immunol; 2009 Feb; 69(2):80-9. PubMed ID: 19144076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunology. The ins and outs of antigen processing and presentation.
    Germain RN
    Nature; 1986 Aug 21-27; 322(6081):687-9. PubMed ID: 3489186
    [No Abstract]   [Full Text] [Related]  

  • 19. DNA vaccination against tumors.
    Prud'homme GJ
    J Gene Med; 2005 Jan; 7(1):3-17. PubMed ID: 15538731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approaches to improved targeting of DNA vaccines.
    Wang G; Pan L; Zhang Y
    Hum Vaccin; 2011 Dec; 7(12):1271-81. PubMed ID: 22108038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.